Leaflet BRIVAL 125mg tablets
Indicated for: herpes zoster
Route of administration: oral
Substance: brivudine (antiviral)
ATC: J05AB15 (Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Brivudine is an antiviral medication used for the treatment of varicella-zoster virus (VZV) infections, particularly in patients with shingles. It works by inhibiting viral replication, reducing the severity and duration of symptoms.
The medication is taken orally, usually once daily, as directed by a doctor. Treatment should be started as soon as possible after symptom onset to be effective.
Common side effects include nausea, headache, and fatigue. In rare cases, allergic reactions or liver function impairment may occur, requiring close monitoring of patients.
Brivudine is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
General data about BRIVAL 125mg
- Substance: brivudine
- Date of latest medicines list: 01-06-2026
- Product code: W12651002
- Concentration: 125mg
- Pharmaceutical form: tablets
- Quantity: 7
- Product type: Original
- Price: 247.92 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Compensation lists for BRIVAL 125mg Berlin Chemie
B - Sublist B with 50% discount from the reference price
Price
Copayment
Patient
247.92 RON
123.96 RON
123.96 RON
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
Price
Copayment
Patient
247.92 RON
247.92 RON
0.00 RON